Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Torok, M Estee ^a,d   Chau, Tran Thin Hong ^b   Mai, Pham Phuong ^b   Phong, Nguyen Duy ^b   Dung, Nguyen Thi ^b   Van Chuong, Ly ^b   Lee, Sue J ^c   Caws, M ^a,d   de Jong, Menno ^a,d   Hien, Tran Tinh ^b   Farrar, Jeremy J ^a,d  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; SODIUM; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANAMNESIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; MULTIVARIATE ANALYSIS; NEUTROPHIL; NONHUMAN; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SYMPTOM; TUBERCULOUS MENINGITIS; VIET NAM; AIDS RELATED COMPLEX; DRUG COMBINATION; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PREVALENCE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; TUBERCULOSIS, MENINGEAL; VIETNAM;

EID: 46349105016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001772     Document Type: Article

References (42)

1. Garg RK (1999) Tuberculosis of the central nervous system. Postgrad Med J 75(881): 133-140.
2. Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, et al. (1992) Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 326(10): 668-672.
3. Girgis NI, Sultan Y, Farid Z, Mansour MM, Erian MW, et al. (1998) Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 58(1): 28-34.
4. Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, et al. (2002) Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 6(1): 64-70.
5. BTS (1998) Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 53(7): 536-548.
6. WHO (2003) Treatment of Tuberculosis: Guidelines for National Programmes. WHO/CDS/Tb2003.313.
7. ATS (2005) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 172(9): 1169-1227.
8. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, et al. (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196 Suppl 1: S86-107.
9. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547): 1575-1580.
10. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, et al. (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 348(2): 119-128.
11. Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, et al. (2005) Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 365(9456): 318-326.
12. Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, et al. (2006) Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 12(9): 1389-1397.
13. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, et al. (2006) Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 10(4): 402-408.
14. Narita M, Ashkin D, Hollender ES, Pitchenik AE (1998) Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158(1): 157-161.
15. Shelburne S 3rd, Hamill R (2003) The immune reconstitution inflammatory syndrome. AIDS Rev 5(2): 67-79.
16. Stoll M, Schmidt RE (2003) Immune restoration inflammatory syndromes: the dark side of successful antiretroviral treatment. Curr Infect Dis Rep 5(3): 266-276.
17. Hirsch HH, Kaufmann G, Sendi P, Battegay M (2004) Immune reconstitution in HIV-infected patients. Clin Infect Dis 38(8): 1159-1166.
18. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, et al. (2003) American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167(4): 603-662.
19. Torok ME (2005) Human immunodeficiency virus associated central nervous system infections. Practical Neurology,. 5: 334-349.
20. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, et al. (2002) Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS Rev 16(1): 75-83.
21. Dheda K, Lampe FC, Johnson MA, Lipman MC (2004) Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 190(9): 1670-1676.
22. WHO (2006) Global tuberculosis control: surveillance, planning, financing. WHO report 2006. Geneva: World Health Organization (WHO/HTM/ TB/2006.362).
23. UNAIDS (2006) AIDS epidemic update: special report on HIV/AIDS. pp 1-96.
24. MRC (1948) Streptomycin treatment of tuberculous meningitis. British Medical Journal i: 582-597.
25. Canetti GFS, Grosset J, Hauduroy P, Langerova M, Mahler HT, et al. (1963) Myobacteria: Laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 29: 565-578.
26. Canetti GFW, Khomenko A, Mitchison DA, Rist N, Smelev NA (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity testing in tuberculosis control programs. Bull World Health Organ 41: 21-43.
27. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, et al. (2004) Dexamethasone for the treatment of tuberculous meningitis in adults and children. N Engl J Med 351(17): 1741-1751.
28. Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD (2000) The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 181(1-2): 118-126.
29. Karande S, Gupta V, Kulkarni M, Joshi A, Rele M (2005) Tuberculous meningitis and HIV. Indian J Pediatr 72(9): 755-760.
30. Thwaites GE, Duc Bang N, Huy Dung N, Thi Quy H, Thi Tuong Oanh D, et al. (2005b) The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis 192(12): 2134-2141.
31. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH (1998) Tuberculous meningitis in South African urban adults. Qjm 91(11): 743-747.
32. Azuaje C, Fernandez Hidalgo N, Almirante B, Martin-Casabona N, Ribera E, et al. (2006) [Tuberculous meningitis: a comparative study in relation to concurrent human immunodeficiency virus infection]. Enferm Infect Microbiol Clin 24(4): 245-250.
33. Thwaites GE, Chau TT, Caws M, Phu NH, Chuong LV, et al. (2002) Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis 6(10): 865-871.
34. Dube MP, Holtom PD, Larsen RA (1992) Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 93(5): 520-524.
35. Yechoor VK, Shandera WX, Rodriguez P, Cate TR (1996) Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med 156(15): 1710-1716.
36. Schutte CM (2001) Clinical, cerebrospinal fluid and pathological findings and outcomes in HIV-positive and HIV-negative patients with tuberculous meningitis. Infection 29(4): 213-217.
37. Enberg GM, Quezada BML, de Toro VC, Fuenzalida LL (2006) [Tuberculous meningitis in adults: review of 53 cases]. Rev Chilena Infectol 23(2): 134-139.
38. Thwaites GE, Tran TH (2005) Tuberculous meningitis: many questions, too few answers. Lancet Neurol, 4(3): 160-70.
39. Simmons CP, Thwaites GE, Quyen NT, Torok E, Hoang DM, et al. (2006) Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome. J Immunol 176(3): 2007-2014.
40. Burman WJ, Stone BL, Reves RR, Wilson ML, Yang Z, et al. (1997) The incidence of false-positive cultures for Mycobacterium tuberculosis. Am J Respir Crit Care Med 155(1): 321-326.
41. Martinez M, de Viedma DG, Alonso M, Andres S, Bouza E, et al. (2006) Impact of laboratory cross-contamination on molecular epidemiology studies of tuberculosis. J Clin Microbiol 44(8): 2967-2969.
42. Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, et al. (2005a) Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 192(1): 79-88.